Congratulations, Halda Therapeutics, on the appointment of Chris Schade as President and Chief Executive Officer! Chris’ proven leadership and successful track record will be an incredible asset to the company as they continue to leverage the RIPTAC platform to improve outcomes for cancer patients. Learn more: https://lnkd.in/e6EeQZGk #VidaPortfolio #HoldandKillCancer
We are excited to announce the appointment of Chris Schade as President and CEO! Chris brings more than 20 years of public and private pharma and biotech industry experience with a strong track record of building and leading biotechnology companies. He will lead Halda as we grow and advance our new cancer fighting modality, #RIPTACtherapeutics, into clinical trials to benefit cancer patients. #HoldandKillCancer https://lnkd.in/e6EeQZGk